FEDERATED HERMES, INC. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 128 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$120,379,132
-12.2%
4,711,512
-1.4%
0.32%
-5.6%
Q2 2023$137,047,380
+19.6%
4,778,5000.0%0.34%
+18.1%
Q1 2023$114,540,645
+59.3%
4,778,500
+12.7%
0.29%
+44.7%
Q4 2022$71,902,836
+36.0%
4,239,554
+18.8%
0.20%
+28.4%
Q3 2022$52,870,000
-5.7%
3,567,497
+0.2%
0.16%
+2.0%
Q2 2022$56,052,000
-44.7%
3,561,097
-5.3%
0.15%
-33.6%
Q1 2022$101,421,000
-25.8%
3,761,900
+1.8%
0.23%
-9.8%
Q4 2021$136,749,000
-6.0%
3,694,929
+21.3%
0.25%
-8.3%
Q3 2021$145,504,000
+42.0%
3,045,288
+0.6%
0.28%
+45.0%
Q2 2021$102,468,000
-22.5%
3,028,000
-5.5%
0.19%
-25.7%
Q1 2021$132,284,000
-11.7%
3,203,000
-7.2%
0.26%
-16.0%
Q4 2020$149,783,000
+153.6%
3,452,810
+150.8%
0.31%
+121.7%
Q3 2020$59,060,000
+105.4%
1,376,675
+123.8%
0.14%
+94.4%
Q2 2020$28,747,000615,0440.07%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2020
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 183,803$9,359,0005.00%
DAFNA Capital Management LLC 229,652$9,852,0003.20%
HealthCor Management, L.P. 1,594,452$68,402,0002.74%
Capital Impact Advisors, LLC 110,000$4,719,0001.40%
Cormorant Asset Management, LP 700,000$30,030,0001.16%
ARK Investment Management 2,495,842$107,072,0000.64%
Millrace Asset Group, Inc. 18,087$776,0000.63%
COOPER CREEK PARTNERS MANAGEMENT LLC 50,532$2,168,0000.54%
Endurant Capital Management LP 34,485$1,479,0000.44%
HealthCor Management, L.P. 200,000$8,580,0000.34%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders